IARC marks Breast Cancer Awareness Month 2025
IARC marks Breast Cancer Awareness Month 2025 Highlighting recent research and global commitments for breast cancer control IARC marks Breast Cancer Awareness Month 2025 The International Agency for Research on Cancer (IARC) observes Breast Cancer Awareness Month 2025 by showcasing the latest global evidence and renewing its call for equitable access to early diagnosis and […]
International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts
Latvia, Riga, 08-10-2025 International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts Personalised Cancer Screening Conference On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga. Organised as part of the EUCanScreen Joint Action, the […]
Marketing bans – the role of advertising in alcohol consumption
24.09.2025 Marketing bans – the role of advertising in alcohol consumption WHO/Europe and IARC examine the impact of alcohol marketing on cancer risk. Advertising in alcohol consumption On 24 September 2025, WHO/Europe and IARC organized a webinar exploring the impact of alcohol advertising on consumption patterns, with a focus on cancer prevention. Alcohol is […]
IARC – Joining new global oral cancer screening network
IARC – Joining new global oral cancer screening network An international call to strengthen collaboration in oral cancer early detection Oral Cancer Screening A new global oral cancer screening network was launched on 29 September 2025 to connect researchers, clinicians, and public health professionals. The initiative, promoted by IARC’s Oral Cancer Team, addresses the urgent […]
IARC launches public consultation on cervical cancer screening approaches
IARC launches public consultation on cervical cancer screening approaches Stakeholder consultation on innovative screening methods for cervical cancer Cervical Cancer Screening On 30 September 2025, IARC opened a global consultation to gather expert and stakeholder input on future cervical cancer screening strategies. Cervical cancer, largely preventable through HPV vaccination and timely testing, still causes significant […]
Reminder – International EUCanScreen conference: Personalised cancer screening lessons learned and the way forward
EUCanScreen International Conference Personalised cancer screening – lessons learned and the way forward October 8, 2025 Large Aula of the University of Latvia, Riga Register Now About the Conference Join us for the International EUCanScreen Conference in the historic city of Riga, Latvia. This pivotal one-day event is dedicated to exploring the future of cancer […]
Toward Lung Cancer Screening in France: The IMPULSION Pilot Program
Toward Lung Cancer Screening in France The IMPULSION Pilot Program Lung cancer remains the leading cause of cancer-related mortality in France, with 30,900 deaths recorded in 2022. Tobacco use is responsible for nearly 80% of diagnosed cases. In 2022, the Haute Autorité de Santé recommended the launch of a pilot program using low-dose […]
Reminder: PMNET Forum 2025 – October 9-10, Riga Latvia
Latvia, Riga, 09.10.2025- 10.10.2025 PMNET Forum 2025 in Riga To improve patient care and outcomes by promoting development and adoption of Precision Medicine Program and Registration
Webinar on alcohol availability policies
Webinar, September 2025 Webinar on alcohol availability policies regulating access to reduce consumption Alcohol availability policies WHO Europe, in partnership with IARC, organised a webinar exploring how limiting the availability of alcohol can reduce consumption and cancer risk. Speakers presented evidence showing that policies such as restricted sales hours, minimum pricing, and reduced retail outlets […]
Evidence-Based Approaches to HPV Screening Implementation
e-oncologia Advancing Cancer Prevention Through Education Evidence-Based Approaches to HPV Screening Implementation Cervical cancer screening is evolving globally due to advances in HPV-based testing, self-sampling, and widespread HPV vaccination. Register Now Course Information This comprehensive online course provides healthcare providers with the latest evidence and practical tools to enhance HPV-based screening, quality assurance, and programme […]
